These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28459562)

  • 1. Overcoming the Limits of Hypoxia in Photodynamic Therapy: A Carbonic Anhydrase IX-Targeted Approach.
    Jung HS; Han J; Shi H; Koo S; Singh H; Kim HJ; Sessler JL; Lee JY; Kim JH; Kim JS
    J Am Chem Soc; 2017 Jun; 139(22):7595-7602. PubMed ID: 28459562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aza-BODIPY based carbonic anhydrase IX: Strategy to overcome hypoxia limitation in photodynamic therapy.
    Pewklang T; Chansaenpak K; Bakar SN; Lai RY; Kue CS; Kamkaew A
    Front Chem; 2022; 10():1015883. PubMed ID: 36405312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
    Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
    Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitors.
    Faes S; Planche A; Uldry E; Santoro T; Pythoud C; Stehle JC; Horlbeck J; Letovanec I; Riggi N; Datta D; Demartines N; Dormond O
    Oncotarget; 2016 Jun; 7(24):36666-36680. PubMed ID: 27153561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
    Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
    Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models.
    Ward C; Meehan J; Mullen P; Supuran C; Dixon JM; Thomas JS; Winum JY; Lambin P; Dubois L; Pavathaneni NK; Jarman EJ; Renshaw L; Um IH; Kay C; Harrison DJ; Kunkler IH; Langdon SP
    Oncotarget; 2015 Sep; 6(28):24856-70. PubMed ID: 26259239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cu(ii)-BODIPY photosensitizer for CAIX overexpressed cancer stem cell therapy.
    Jung HS; Koo S; Won M; An S; Park H; Sessler JL; Han J; Kim JS
    Chem Sci; 2023 Feb; 14(7):1808-1819. PubMed ID: 36819853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
    Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
    Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis.
    Andreucci E; Peppicelli S; Carta F; Brisotto G; Biscontin E; Ruzzolini J; Bianchini F; Biagioni A; Supuran CT; Calorini L
    J Mol Med (Berl); 2017 Dec; 95(12):1341-1353. PubMed ID: 28929255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological evaluation of p-toluene sulphonylhydrazone as carbonic anhydrase IX inhibitors: An approach to fight hypoxia-induced tumors.
    Queen A; Khan P; Idrees D; Azam A; Hassan MI
    Int J Biol Macromol; 2018 Jan; 106():840-850. PubMed ID: 28830777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells.
    Meehan J; Ward C; Turnbull A; Bukowski-Wills J; Finch AJ; Jarman EJ; Xintaropoulou C; Martinez-Perez C; Gray M; Pearson M; Mullen P; Supuran CT; Carta F; Harrison DJ; Kunkler IH; Langdon SP
    Oncotarget; 2017 Jun; 8(26):42857-42875. PubMed ID: 28476026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion.
    Robertson N; Potter C; Harris AL
    Cancer Res; 2004 Sep; 64(17):6160-5. PubMed ID: 15342400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual screening, molecular dynamics, and binding free energy calculations on human carbonic anhydrase IX catalytic domain for deciphering potential leads.
    John A; Sivashanmugam M; Umashankar V; Natarajan SK
    J Biomol Struct Dyn; 2017 Aug; 35(10):2155-2168. PubMed ID: 27373313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approach of delivering cytotoxic drugs towards CAIX expressing cells: A concept of dual-target drugs.
    van Kuijk SJA; Parvathaneni NK; Niemans R; van Gisbergen MW; Carta F; Vullo D; Pastorekova S; Yaromina A; Supuran CT; Dubois LJ; Winum JY; Lambin P
    Eur J Med Chem; 2017 Feb; 127():691-702. PubMed ID: 27823879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells.
    Ivanova L; Zandberga E; Siliņa K; Kalniņa Z; Ābols A; Endzeliņš E; Vendina I; Romanchikova N; Hegmane A; Trapencieris P; Eglītis J; Linē A
    Cancer Chemother Pharmacol; 2015 Feb; 75(2):235-46. PubMed ID: 25422154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and radiobiological effects of carbonic anhydrase IX in human breast cancer cells.
    Güttler A; Theuerkorn K; Riemann A; Wichmann H; Kessler J; Thews O; Bache M; Vordermark D
    Oncol Rep; 2019 Apr; 41(4):2585-2594. PubMed ID: 30720123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression and function of CAIX and CAXII in breast cancer: A comparison between tumorgraft models and cells.
    Chen Z; Ai L; Mboge MY; Tu C; McKenna R; Brown KD; Heldermon CD; Frost SC
    PLoS One; 2018; 13(7):e0199476. PubMed ID: 29965974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Small Molecule Tubulysin B Conjugate for Treatment of Carbonic Anhydrase IX Receptor Expressing Cancers.
    Marks IS; Gardeen SS; Kurdziel SJ; Nicolaou ST; Woods JE; Kularatne SA; Low PS
    Mol Pharm; 2018 Jun; 15(6):2289-2296. PubMed ID: 29715036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-Targeting Fluorescent Nanobodies for Optical Molecular Imaging of Pre-Invasive Breast Cancer.
    van Brussel AS; Adams A; Oliveira S; Dorresteijn B; El Khattabi M; Vermeulen JF; van der Wall E; Mali WP; Derksen PW; van Diest PJ; van Bergen En Henegouwen PM
    Mol Imaging Biol; 2016 Aug; 18(4):535-44. PubMed ID: 26589824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organic Photodynamic Nanoinhibitor for Synergistic Cancer Therapy.
    Jiang Y; Li J; Zeng Z; Xie C; Lyu Y; Pu K
    Angew Chem Int Ed Engl; 2019 Jun; 58(24):8161-8165. PubMed ID: 30993791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.